Greenwich Lifesciences Inc (GLSI) is around the top of the Biotechnology industry according to InvestorsObserver. GLSI received an overall rating of 62, which means that it scores higher than 62 percent of all stocks. Greenwich Lifesciences Inc also achieved a score of 73 in the Biotechnology industry, putting it above 73 percent of Biotechnology stocks. Biotechnology is ranked 36 out of the 148 industries.
GLSI has an Overall Score of 62. Find out what this means to you and get the rest of the rankings on GLSI!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Greenwich Lifesciences Inc Stock Today?
Greenwich Lifesciences Inc (GLSI) stock is trading at $13.15 as of 2:48 PM on Thursday, Apr 6, a gain of $0.39, or 3.06% from the previous closing price of $12.76. The stock has traded between $12.83 and $13.64 so far today. Volume today is 27,890 compared to average volume of 36,306.
Click Here to get the full Stock Report for Greenwich Lifesciences Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
